HLS

HealiusASX:HLS Stock Report

Market Cap

AU$3.0b

7D

1.6%

1Y

48.8%

Updated

18 Sep, 2021

Data

Company Financials +
HLS fundamental analysis
Snowflake Score
Valuation1/6
Future Growth1/6
Past Performance2/6
Financial Health4/6
Dividends3/6

HLS Overview

Healius Limited provides facilities and support services to independent general practitioners, radiologists, and other healthcare professionals in Australia.

Share Price & News

How has Healius's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: HLS is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: HLS's weekly volatility (4%) has been stable over the past year.


Market Performance


7 Day Return

1.6%

HLS

1.9%

AU Healthcare

-0.02%

AU Market


1 Year Return

48.8%

HLS

23.6%

AU Healthcare

27.0%

AU Market

Return vs Industry: HLS exceeded the Australian Healthcare industry which returned 23.6% over the past year.

Return vs Market: HLS exceeded the Australian Market which returned 27% over the past year.


Shareholder returns

HLSIndustryMarket
7 Day1.6%1.9%-0.02%
30 Day-5.4%1.6%-0.5%
90 Day12.8%10.0%0.7%
1 Year53.3%48.8%26.6%23.6%32.4%27.0%
3 Year83.1%71.5%52.5%41.3%35.9%19.3%
5 Year41.0%20.8%30.9%14.0%65.4%32.7%

Long-Term Price Volatility Vs. Market

How volatile is Healius's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Healius Fundamentals Summary

How do Healius's earnings and revenue compare to its market cap?
HLS fundamental statistics
Market CapAU$2.95b
Earnings (TTM)AU$66.30m
Revenue (TTM)AU$1.91b

44.6x

P/E Ratio

1.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
HLS income statement (TTM)
RevenueAU$1.91b
Cost of RevenueAU$1.19b
Gross ProfitAU$725.50m
ExpensesAU$659.20m
EarningsAU$66.30m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.11
Gross Margin37.90%
Net Profit Margin3.46%
Debt/Equity Ratio14.2%

How did HLS perform over the long term?

See historical performance and comparison

Dividends

2.7%

Current Dividend Yield

124%

Payout Ratio

Valuation

Is Healius undervalued compared to its fair value and its price relative to the market?

44.56x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: HLS (A$4.94) is trading above our estimate of fair value (A$4.3)

Significantly Below Fair Value: HLS is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: HLS is poor value based on its PE Ratio (44.6x) compared to the Australian Healthcare industry average (26.5x).

PE vs Market: HLS is poor value based on its PE Ratio (44.6x) compared to the Australian market (18.7x).


Price to Earnings Growth Ratio

PEG Ratio: HLS is poor value based on its PEG Ratio (5.8x)


Price to Book Ratio

PB vs Industry: HLS is good value based on its PB Ratio (1.6x) compared to the AU Healthcare industry average (2.4x).


Future Growth

How is Healius forecast to perform in the next 1 to 3 years based on estimates from 13 analysts?

7.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: HLS's forecast earnings growth (7.7% per year) is above the savings rate (1.9%).

Earnings vs Market: HLS's earnings (7.7% per year) are forecast to grow slower than the Australian market (11.5% per year).

High Growth Earnings: HLS's earnings are forecast to grow, but not significantly.

Revenue vs Market: HLS's revenue is expected to decline over the next 3 years (-0.08% per year).

High Growth Revenue: HLS's revenue is forecast to decline over the next 3 years (-0.08% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: HLS's Return on Equity is forecast to be low in 3 years time (7.5%).


Past Performance

How has Healius performed over the past 5 years?

51.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: HLS has high quality earnings.

Growing Profit Margin: HLS's current net profit margins (3.5%) are lower than last year (5.3%).


Past Earnings Growth Analysis

Earnings Trend: HLS has become profitable over the past 5 years, growing earnings by 51.1% per year.

Accelerating Growth: HLS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: HLS had negative earnings growth (-20.5%) over the past year, making it difficult to compare to the Healthcare industry average (61.3%).


Return on Equity

High ROE: HLS's Return on Equity (3.6%) is considered low.


Financial Health

How is Healius's financial position?


Financial Position Analysis

Short Term Liabilities: HLS's short term assets (A$330.9M) do not cover its short term liabilities (A$684.7M).

Long Term Liabilities: HLS's short term assets (A$330.9M) do not cover its long term liabilities (A$1.2B).


Debt to Equity History and Analysis

Debt Level: HLS's debt to equity ratio (14.2%) is considered satisfactory.

Reducing Debt: HLS's debt to equity ratio has reduced from 37.5% to 14.2% over the past 5 years.

Debt Coverage: HLS's debt is well covered by operating cash flow (198.8%).

Interest Coverage: HLS's interest payments on its debt are well covered by EBIT (4.5x coverage).


Balance Sheet


Dividend

What is Healius's current dividend yield, its reliability and sustainability?

2.73%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: HLS's dividend (2.73%) is higher than the bottom 25% of dividend payers in the Australian market (2.3%).

High Dividend: HLS's dividend (2.73%) is low compared to the top 25% of dividend payers in the Australian market (5.41%).


Stability and Growth of Payments

Stable Dividend: HLS's dividend payments have been volatile in the past 10 years.

Growing Dividend: HLS's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its high payout ratio (123.7%), HLS's dividend payments are not well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: HLS's dividends in 3 years are forecast to be covered by earnings (61.1% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.0yrs

Average management tenure


CEO

Malcolm Parmenter (66 yo)

4yrs

Tenure

AU$3,232,745

Compensation

Dr. Malcolm W. Parmenter, MB, BS, MAICD, has been the Managing Director and Chief Executive Officer at Healius Limited (formerly known as Primary Health Care Limited) since joined on September 06, 2017 & s...


CEO Compensation Analysis

Compensation vs Market: Malcolm's total compensation ($USD2.35M) is above average for companies of similar size in the Australian market ($USD1.28M).

Compensation vs Earnings: Malcolm's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


Leadership Team

Experienced Management: HLS's management team is considered experienced (3 years average tenure).


Board Members

Experienced Board: HLS's board of directors are considered experienced (3.2 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: HLS insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Healius Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Healius Limited
  • Ticker: HLS
  • Exchange: ASX
  • Founded: 1994
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: AU$2.954b
  • Shares outstanding: 598.01m
  • Website: https://www.healius.com.au

Number of Employees


Location

  • Healius Limited
  • 203 Pacific Highway
  • Level 6
  • St Leonards
  • New South Wales
  • 2065
  • Australia

Listings


Biography

Healius Limited provides facilities and support services to independent general practitioners, radiologists, and other healthcare professionals in Australia. The company operates through three segments: Pa...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/18 08:03
End of Day Share Price2021/09/17 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.